Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets

Hiroyasu Hatakeyama1, Takuya Kishimoto, Tomomi Nemoto

  • 1Department of Cell Physiology, National Institute for Physiological Sciences, Okazaki, Japan.

The Journal of Physiology
|November 15, 2005
PubMed

Insights

Protein kinase A (PKA) is crucial for the first phase of glucose-induced exocytosis, regulating insulin release by influencing fusion events. PKA

Area of Science:

  • Endocrinology
  • Cell Biology
  • Molecular Biology

Background:

  • Insulin exocytosis is a complex process regulated by various signaling pathways.
  • Glucose-induced exocytosis (GIE) is critical for maintaining glucose homeostasis.
  • The precise role of protein kinase A (PKA) in GIE requires further elucidation.

Purpose of the Study:

  • To investigate the role of PKA in glucose-induced insulin exocytosis.
  • To determine the specific phase of GIE affected by PKA.
  • To elucidate the mechanism by which PKA influences insulin secretion.

Main Methods:

  • Two-photon excitation imaging of mouse islets of Langerhans.
  • Selective inhibition of PKA activity.
  • Measurement of intracellular calcium ([Ca(2+)](i)) levels.
  • Study of Ca(2+)-induced insulin exocytosis (CIE) using photolysis of caged-Ca(2+).

Main Results:

  • PKA inhibition selectively reduced exocytic events during the initial phase of GIE.
  • PKA inhibitors did not affect the glucose-induced increase in intracellular calcium.
  • High glucose potentiated CIE, an effect blocked by PKA inhibitors and dependent on glucose metabolism.
  • PKA appeared to reduce 'kiss-and-run' exocytosis and promote full-fusion events.

Conclusions:

  • A PKA-dependent mechanism is essential for the first phase of GIE.
  • PKA plays a significant role in glucose sensing and insulin exocytosis.
  • PKA's action is likely mediated at the level of the fusion reaction during exocytosis.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...